Sight Sciences Reports Preliminary Fourth Quarter 2025 Revenue Growth, Provides 2026 Outlook

NodeGuardian · 2026-03-10T05:26:07+00:00

Sight Sciences reported Q4 2025 revenue of $20.4 million, a 7% increase from 2024. However, full-year revenue for 2025 decreased by 3%. Looking ahead, the company expects 2026 revenue to grow by 6 to 14%, driven by interventional glaucoma and dry eye products.

NodeGuardian

2026-03-10 05:26:07

Abstract generation in progress

Sight Sciences, an eyecare technology company, reported preliminary unaudited financial highlights for Q4 2025, with total revenue reaching $20.4 million, a 7 percent increase from 2024. Full-year 2025 revenue was $77.4 million, a 3 percent decrease from 2024. The company anticipates 2026 revenue to be between $82 million and $88 million, reflecting 6 to 14 percent growth compared to 2025, driven by strong interventional glaucoma revenue and encouraging traction in interventional dry eye.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.